Publications in collaboration with researchers from Örebro University (1)

2022

  1. Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes

    Diabetes/Metabolism Research and Reviews, Vol. 38, Núm. 3